JAK2 and neoplasm: Further bulk RNA-seq analysis revealed that LIES activated the JAK2-STAT3 pathway, inducing expression of PD-L1 in PDAC cells.<h4>Conclusions</h4>Anti-PD-1 blockade can reverse LIES-driven tumor progression by upregulating CD8<sup>+</sup> T cell expression.